Cargando…
Testicular cancer follow-up costs in Germany from 2000 to 2015
PURPOSE: Advances in testicular cancer screening and therapy increased 10-year survival to 97% despite a rising incidence; eventually expanding the population of survivors requiring follow-up. We analyzed 10-year follow-up costs after testicular cancer treatment in Germany during 2000, 2008, and 201...
Autores principales: | Michaeli, Thomas, Michaeli, Julia, Michaeli, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236467/ https://www.ncbi.nlm.nih.gov/pubmed/33885951 http://dx.doi.org/10.1007/s00432-021-03643-1 |
Ejemplares similares
-
Prostate cancer follow-up costs in Germany from 2000 to 2015
por: Michaeli, Thomas, et al.
Publicado: (2021) -
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
por: Michaeli, Daniel Tobias, et al.
Publicado: (2022) -
Cost-Effectiveness of Icosapent Ethyl, Evolocumab, Alirocumab, Ezetimibe, or Fenofibrate in Combination with Statins Compared to Statin Monotherapy
por: Michaeli, Daniel Tobias, et al.
Publicado: (2022) -
Advances in cancer therapy: clinical benefit of new cancer drugs
por: Michaeli, Daniel Tobias, et al.
Publicado: (2023) -
Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa
por: Michaeli, Daniel Tobias, et al.
Publicado: (2022)